Comparison
Clarivate offers deep proprietary life sciences databases. Salesmotion delivers AI-powered account intelligence from public sources at a fraction of the price. This guide helps life sciences commercial teams understand the trade-offs.
| Feature | Clarivate (Life Sciences & Healthcare) | Salesmotion |
|---|---|---|
| Primary Function | Proprietary life sciences data & analytics | AI-powered account intelligence & selling signals |
| Core Audience | Pharma R&D, regulatory affairs, commercial strategy | BD, sales, and commercial teams |
| Data Sources | Proprietary curated databases (Cortellis, DRG) | 1,000+ public sources synthesized by AI |
| Clinical Trials | 325,000+ trials with proprietary metadata | Scans & consolidates trials globally from ClinicalTrials.gov and public registries |
| Setup Time | Weeks to months (enterprise onboarding) | 20 minutes — live the same day |
| Pricing | Six figures annually ($100K–$500K+) | From $85/mo (account-based, unlimited users on team plans) |
Clarivate's Life Sciences & Healthcare division is a legacy data, analytics, and consulting business serving pharma, biotech, CROs, and medtech companies. Its flagship products include the Cortellis suite (drug pipeline intelligence, regulatory data, clinical trial analytics) and the DRG portfolio (real-world data, commercial analytics, and market access consulting).
The LS&HC business generated $390M in revenue in 2025, though it declined 6.9% year-over-year. In February 2026, Clarivate announced it is exploring a sale of the entire division, appointing Morgan Stanley as financial advisor. The rationale is to focus on its Academia & Government and Intellectual Property segments and use proceeds to reduce its $4.6B debt load.
Clarivate's strength is proprietary, curated datasets — particularly in regulatory intelligence, clinical trial tracking, and drug pipeline analytics. These are deep, structured databases built over decades. The challenge is that these products carry enterprise-level pricing (six-figure annual contracts), long implementation timelines, and increasingly face competition from AI-native platforms that can synthesize much of the same publicly available information at a fraction of the cost.
Best for: Pharma R&D teams, regulatory affairs, and commercial strategy groups that need proprietary clinical trial data, drug pipeline intelligence, and regulatory filings across 80+ jurisdictions
Pricing: Enterprise contracts typically six figures annually ($100K–$500K+). Multi-year commitments common. Pricing varies by modules, seats, and data access levels. Not publicly listed.
Salesmotion is an AI-powered account intelligence platform that helps sales, BD, and commercial teams research accounts, track buying signals, and personalize outreach — all from publicly available data sources. It synthesizes intelligence from over 1,000 sources (news, earnings calls, job postings, press releases, SEC filings, clinical trial registries, leadership changes) into actionable account briefs.
Salesmotion does not have proprietary internally curated clinical trial databases like Clarivate. However, it actively scans and consolidates clinical trial data globally from ClinicalTrials.gov and equivalent public registries, alongside real-time signal monitoring across 1,000+ other public sources. Combined with AI-generated talking points and a modern interface that takes 20 minutes to set up, it provides life sciences BD and sales teams 80–90% of the account context they need at a fraction of the cost.
Cytel, a 2,000+ person life sciences analytics company, consolidated 5 research tools into Salesmotion and cut research time by 50%. The platform is increasingly adopted by CROs, biotech companies, and pharma commercial teams that need account intelligence for selling — not R&D pipeline analysis.
Best for: Life sciences BD, sales, and commercial teams that need account intelligence, buying signals, and personalized outreach — without six-figure data contracts
G2 rating: 4.8/5
Pricing: From $85/mo — flexible account-based pricing, unlimited users on team plans
How Clarivate (Life Sciences & Healthcare) and Salesmotion stack up across key capabilities.
| Feature | Clarivate (Life Sciences & Healthcare) | Salesmotion |
|---|---|---|
| Drug Pipeline Data | 70,000+ targets with proprietary curation | Pipeline tracking from public registries, news, and press releases |
| Regulatory Intelligence | 80+ jurisdictions, structured filings | FDA/EMA news monitoring via public sources |
| Real-World Data (Claims) | DRG Fusion with patient-level claims data | Not a claims data provider |
| Account Research | Company profiles within LS&HC context | Comprehensive AI briefs from 1,000+ sources |
| Buying Signals | Limited — data platform, not a signal engine | 24/7 monitoring: earnings, hiring, leadership, news, trials |
| AI Talking Points | Not included | Auto-generated from real account events |
| Outreach Support | No outreach tools | AI-drafted emails anchored to account research |
| CRM Integration | Limited | Salesforce-native with embedded views |
| Cross-Signal Search | Search within individual databases | Full-text search across all data types and accounts |
| Setup & Time-to-Value | Enterprise implementation (weeks–months) | 20-minute setup, live same day |
Clarivate's Life Sciences & Healthcare products are sold as enterprise subscriptions, typically ranging from $100K to $500K+ per year depending on modules, seats, and data access. Multi-year contracts are common, and implementation requires dedicated onboarding. For a mid-size CRO or biotech company, Clarivate can represent one of the largest line items in the sales intelligence budget.
Salesmotion starts at $85/month for individuals and $990/month for teams with unlimited users. There are no per-seat multipliers, no multi-year lock-ins, and no implementation project. A life sciences BD team of 10 people pays the same as a team of 50. That means a full year of Salesmotion costs less than a single month of most Clarivate contracts.
The honest trade-off: Clarivate offers proprietary curated data that Salesmotion does not replicate — particularly structured regulatory filings, claims-level real-world data, and deep drug pipeline metadata. But for account intelligence, buying signals, meeting prep, and outreach personalization, Salesmotion delivers 80–90% of the value at roughly 80–90% less cost. Many life sciences teams are finding that the combination — keeping selective proprietary data subscriptions while using Salesmotion for day-to-day account intelligence — is the most cost-effective approach. See how Cytel consolidated 5 tools into Salesmotion.
“All of the vendors that I've worked with, all of the onboarding that I have had to deal with, I will say, hands down, Salesmotion was the easiest that I have had.”
Lyndsay Thomson
Head of Sales Operations, Cytel
Salesmotion gives your reps the account intelligence they need to book more meetings and close bigger deals.
It depends on what you use Clarivate for. If your team relies on proprietary drug pipeline data (Cortellis), patient-level claims data (DRG Fusion), or structured regulatory filings, Salesmotion does not replicate those datasets. But if your primary use case is account research, buying signals, meeting prep, and outreach personalization for BD and sales, Salesmotion provides the account intelligence you need at a fraction of the cost. Many life sciences companies — including Cytel — have consolidated 5+ research tools into Salesmotion and cut research time by 50%. The most common pattern is keeping selective Clarivate modules for R&D while using Salesmotion for commercial and BD workflows.
Salesmotion actively scans and consolidates clinical trial data globally from ClinicalTrials.gov and equivalent public registries worldwide, as well as FDA and EMA announcements, company press releases, and news coverage. The platform tracks when target accounts start new trials, hit milestones, or announce results — and synthesizes this into account-level intelligence with AI-generated talking points. The difference from Clarivate is not coverage but depth of proprietary metadata: Cortellis adds internally curated fields, analyst annotations, and structured pipeline classifications that go beyond what public registries provide.
Clarivate announced in February 2026 that it is exploring a sale of its Life Sciences & Healthcare business, with Morgan Stanley as advisor. For existing customers, this creates uncertainty around product roadmaps, pricing, and support. Historically, when PE firms acquire data businesses, customers see price increases and product bundling changes. This is precisely the kind of transition that makes teams evaluate alternatives — and why many are proactively exploring more agile, cost-effective platforms.
Yes. Salesmotion has a growing base of life sciences customers, with Cytel being the flagship example. The platform's clinical trial monitoring, earnings call analysis, and leadership tracking are particularly relevant for CROs, CDMOs, and biotech companies selling into pharma accounts. The 20-minute setup, month-to-month pricing, and unlimited users make it especially attractive for teams that need intelligence without the overhead of legacy enterprise data contracts.
Significantly. Clarivate LS&HC contracts typically run $100K–$500K+ per year. Salesmotion team plans start at $990/month ($11,880/year) with unlimited users. That means a full year of Salesmotion can cost less than a single month of Clarivate. The trade-off is data depth — Clarivate offers proprietary datasets Salesmotion does not have. But for the account intelligence, signals, and selling workflows that BD and sales teams use daily, Salesmotion delivers exceptional value per dollar.
Account intelligence, live signals, and AI-driven outreach — so your team spends less time researching and more time closing.
